Apotheker auf der Palliativstation: Auswirkung auf Arzneimitteltherapie und Therapiekosten

Wolf, Carolin; Dörje, Frank; Klein, C. P. A. T.; Ostgathe, Christoph

doi:10.1007/s00482-019-00405-4

Cited by 2 publications

(8 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The cost savings of integrating a part-time (20% effort) clinical pharmacist in an inpatient 10-bed palliative care unit in Germany was reported by Wolf et al 26 This report showed that pharmaceutical interventions on drug selection and dosing were highly accepted by providers (93% acceptance rate), and the cost savings of the interventions made covered 83% of the cost of the clinical pharmacy service. The pharmacist also developed operating procedures regarding the use of subcutaneous medications.…”

Section: Literature Search Resultsmentioning

confidence: 83%

“…Seven original articles described inpatient palliative and hospice care (PHC) pharmacy services, see Table 1. [20][21][22][23][24][25][26] Lucas et al (1997) first described the role of a PHC pharmacist specialized in acquired immunodeficiency syndrome (AIDS) in a 35-bed palliative unit in Australia. 20 The report described the role of a part-time pharmacy faculty in a teaching hospital.…”

Section: Literature Search Resultsmentioning

confidence: 99%

“…22 The main activities of a PHC pharmacist in inpatient settings included direct patient care involving deprescribing, pain and symptom management, team rounds, and providing education for staff, patients, and caregivers. [20][21][22][23][24][25][26] The cost saving of having a PHC pharmacist in the inpatient palliative care team were emphasized in 5 articles. 20,21,[23][24][25][26]…”

Section: Literature Search Resultsmentioning

confidence: 99%

“…[20][21][22][23][24][25][26] The cost saving of having a PHC pharmacist in the inpatient palliative care team were emphasized in 5 articles. 20,21,[23][24][25][26]…”

Section: Literature Search Resultsmentioning

confidence: 99%

“…A summary of a PHC pharmacist's key roles and responsibilities at the MEDVAMC is described in Table 2. The pharmacist's activities resemble what has been described in the literature in conducting medication reviews, [20][21][22][23][24][25] coordinating the transition of care, [21][22][23][24][25] symptom management, [21][22][23][24][25][26] and education to the patient and team. [20][21][22][23][24][25][26][27] Additionally, at MEDVAMC, the PHC pharmacist creates a comprehensive palliative care medication assessment upon admission by comparing the current, previous inpatient, and outpatient medications to examine medication changes at each transition of care.…”

Section: Medication Reconciliation During Transition Of Carementioning

confidence: 96%

See 4 more Smart Citations

The Role of an Inpatient Hospice and Palliative Clinical Pharmacist in the Interdisciplinary Team

Moody

Poon

Braun

2021

Am J Hosp Palliat Care

View full text Add to dashboard Cite

Palliative care is a specialized health care service for individuals with serious illness at any stage and can be provided in any setting. Current national consensus developed by palliative care experts recommends the inclusion of pharmacists in an interdisciplinary team (IDT) to provide quality palliative care. However, national registry data report that less than 10% of inpatient palliative teams in the U.S. have a clinical pharmacist. Clinical pharmacists have an impactful role in palliative patients’ quality of life by optimizing symptom management, deprescribing, and providing education to the palliative care team as well as patients and their families. In this report, we review the current literature on the role of a palliative pharmacist in an inpatient palliative care setting and compare and contrast this with our own clinical practice, providing case examples about the role of a palliative clinical pharmacist in an interdisciplinary inpatient palliative care setting. Future strategies are needed to increase post-graduate specialized pharmacy residency training in palliative care as well as education on palliative and hospice care in pharmacy schools to support the role of clinical pharmacists in palliative care.

show abstract

Section: Literature Search Resultsmentioning

confidence: 83%

Section: Literature Search Resultsmentioning

confidence: 99%

Section: Literature Search Resultsmentioning

confidence: 99%

“…[20][21][22][23][24][25][26] The cost saving of having a PHC pharmacist in the inpatient palliative care team were emphasized in 5 articles. 20,21,[23][24][25][26]…”

Section: Literature Search Resultsmentioning

confidence: 99%

Section: Medication Reconciliation During Transition Of Carementioning

confidence: 96%

See 3 more Smart Citations

The Role of an Inpatient Hospice and Palliative Clinical Pharmacist in the Interdisciplinary Team

Moody

Poon

Braun

2021

Am J Hosp Palliat Care

View full text Add to dashboard Cite

show abstract

Drug Therapy Safety in Palliative Care—Pharmaceutical Analysis of Medication Processes in Palliative Care

Krumm,

Bausewein,

Rémi

2023

Pharmacy

View full text Add to dashboard Cite

Pharmacotherapy plays a crucial role in symptom management in palliative care and is associated with risks potentially leading to drug-related problems (DRP). Pharmacists can identify DRPs and advise prescribers on optimizing drug therapy. The aim of this study was to identify DRP in a palliative care unit (PCU) and evaluate corresponding pharmaceutical interventions. A non-randomized before-and-after study in a PCU starts with a control phase, an interphase, and an intervention phase. Primary endpoint: DRP, including pharmaceutical interventions and their acceptance. The medication of all inpatients was recorded at set time points, assessed for potential and manifest DRP, and categorized. In the control phase, the ward pharmacist did not interfere with the clinical team. In the intervention phase, the pharmacist could intervene when a DRP was identified and give recommendations. During the 12-month period, 284 patients were included (control phase n = 138; intervention phase n = 146) and 1079 DRPs were identified (control phase n = 634; intervention phase n = 445). The number of DRPs/patient was significantly reduced by the pharmacist’s interventions between the control and intervention phases (4 vs. 3 DRPs, p = 0.001). Overall acceptance of pharmaceutical interventions by prescribers was very high (227/256; 88%). DRPs are hardly preventable. With a clinical pharmacist as a member of the palliative care team, it is possible to reduce the number of DRPs and identify potential problems earlier.

show abstract

Apotheker auf der Palliativstation: Auswirkung auf Arzneimitteltherapie und Therapiekosten

Cited by 2 publications

References 15 publications

The Role of an Inpatient Hospice and Palliative Clinical Pharmacist in the Interdisciplinary Team

The Role of an Inpatient Hospice and Palliative Clinical Pharmacist in the Interdisciplinary Team

Drug Therapy Safety in Palliative Care—Pharmaceutical Analysis of Medication Processes in Palliative Care

Contact Info

Product

Resources

About